Latest news
Tau Is Back. Certainty Is Not.
Biogen’s diranersen data at AAIC show a serious tau-lowering signal in Alzheimer’s disease. They also show why biomarker enthusiasm still needs a harder clinical test.
IPM Brief – Issue 8 | The Trial Is Now a Border
Europe Opens Another Lung Cancer Door to China-Origin Immunotherapy
In Australia, Cancer Medicine Delays Cost More Than Time
Neurology Is Trying to Stop Nerves Dying, Not Just Treat What Is Left
South Sudan Has a New Health Deal. Now It Needs a Delivery System.
AI Improved Sepsis Compliance. Patients Still Need the Outcome Proof.
Cardiac rehab saves lives. Health systems still treat it like optional aftercare
BMI is not enough. Cardiometabolic risk is hiding in where fat lives
Cancer Progress Still Depends on Your Postcode
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.